Regulation - Rest of the World, Oncology

Filter

Current filters:

Rest of the WorldOncology

Popular Filters

Brain tumor visualization drug approved in Australia

Brain tumor visualization drug approved in Australia

11-11-2013

A novel drug which assists neurosurgeons to better visualize and remove malignant brain tumors has been…

AustraliaGliolanOncologyPharmaceuticalRegulationRest of the WorldSpecialised Therapeutics Australia

Eisai expands in South Africa, filing for approval of Halaven and Fycompa

30-01-2013

Japanese drug major Eisai (TYO: 4523) says it is expanding its operations into South Africa, with the…

EisaiFycompaHalavenMarkets & MarketingNeurologicalOncologyPharmaceuticalRegulationRest of the World

Company Spotlight

ImmunoGen

ImmunoGen

Back to top